CClinicalTrials.gg
Status unknownNCT04707339Updated Jan 14, 2021

Management of Acute Appendicitis at District General Hospital

An observational study in Appendicitis Acute and Covid19, sponsored by Princess Alexandra Hospital NHS Trust. Status unknown at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2021-01-14.

Sponsored by Princess Alexandra Hospital NHS Trust · Observational

The sponsor has not verified this record recently (last verified Jan 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
200
Sex
All
01

Study summary

The Investigators aim to assess;

  1. whether the changes in managing patients during COVID has reduced the negative appendicectomy rate?
  2. compare the difference in outcomes of conservatively and surgically managed Acute Appendicitis?
  3. Whether there uniformity in prescribing postoperative antibiotics with resultant outcomes?
  4. Whether the incidence of complicated appendicitis has increased?
Read the detailed description

As acute appendicitis is the most commonly managed emergency presentation for surgeons, the investigators aim to assess whether the changes in managing patients during COVID has reduced the negative appendicectomy rate, to compare the difference in outcomes of conservatively and surgically managed Acute Appendicitis? to assess whether there uniformity in prescribing postoperative antibiotics with resultant outcomes? to assess whether the incidence of complicated appendicitis has increased? This will be a single centre retrospective observational study. All the patients presenting in A\&E department with a diagnosis of acute appendicitis to be included. the only exclusion criteria are the age of participants for less than 5 years. The data will be analysed and calculated using SPSS version 23.

02

Conditions studied

  • Appendicitis Acute
  • Covid19

Keywords

  • Acute Appendicitis
  • COVID-19 pandemic
  • Management
03

In context

COVID-19

7,638 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 200 is below the median of 260 across 3,135 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

This is the only study on the registry with Princess Alexandra Hospital NHS Trust as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All patients with a diagnosis of Acute Appendicitis will be included

Inclusion criteria

  • All participants reporting in accident and emergency with a diagnosis of acute appendicitis irrespective of age above 5 years, gender and morbidities (this group for conservative management)

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Acute Appendicitis pre-COVID management

    Audit of Acute appendicitis management in 2017-18

    Procedure: Appendicectomy

  • Acute Appendicitis during COVID management

    Audit of Acute appendicitis management in 2020

    Procedure: Appendicectomy

Interventions

  • ProcedureAppendicectomy

    Laparoscopic or Open Appendicectomy

06

What researchers measure

Primary outcomes

  1. Negative Appendicectomy Rate

    Negative appendicectomy rate will be calculated to define the benefits of increasing the preoperative scanning in the form of ultrasound, CT scan or both.

    Time frame: 8 months

  2. Outcomes of Conservative vs Operative Management

    The outcomes of both conservatively and operatively managed patients will be assessed to define the best management approach.

    Time frame: 8 months

  3. Increased Open Appendicectomy Rate

    The rate of laparoscopic to open and open appendicectomy rate will be calculated to understand if the surgical practice has been changed during COVID-19 pandemic?

    Time frame: 8 months

  4. Surgical site infection in patients on antibiotics

    The rate of incidence of superficial and deep wound infection will be calculated to define the applicability of use of Antibiotics

    Time frame: 8 months

Secondary outcomes

  1. Length of Stay

    The number of days of postoperative admission in hospital will be assessed while comparing the type of surgery and co-morbidities.

    Time frame: 8 months

07

Study locations

1 of 1 sites recruiting
  • The Princess Alexandra Hospital NHS Trust
    Harlow, Essex CM20 1EL, United Kingdom
    Recruiting
08

References and documents

Publications

  • Hori T, Machimoto T, Kadokawa Y, Hata T, Ito T, Kato S, Yasukawa D, Aisu Y, Kimura Y, Sasaki M, Takamatsu Y, Kitano T, Hisamori S, Yoshimura T. Laparoscopic appendectomy for acute appendicitis: How to discourage surgeons using inadequate therapy. World J Gastroenterol. 2017 Aug 28;23(32):5849-5859. doi: 10.3748/wjg.v23.i32.5849. PubMed 28932077 ↗
  • van den Boom AL, de Wijkerslooth EML, van Rosmalen J, Beverdam FH, Boerma EG, Boermeester MA, Bosmans JWAM, Burghgraef TA, Consten ECJ, Dawson I, Dekker JWT, Emous M, van Geloven AAW, Go PMNYH, Heijnen LA, Huisman SA, Jean Pierre D, de Jonge J, Kloeze JH, Koopmanschap MA, Langeveld HR, Luyer MDP, Melles DC, Mouton JW, van der Ploeg APT, Poelmann FB, Ponten JEH, van Rossem CC, Schreurs WH, Shapiro J, Steenvoorde P, Toorenvliet BR, Verhelst J, Versteegh HP, Wijnen RMH, Wijnhoven BPL. Two versus five days of antibiotics after appendectomy for complex acute appendicitis (APPIC): study protocol for a randomized controlled trial. Trials. 2018 May 2;19(1):263. doi: 10.1186/s13063-018-2629-0. PubMed 29720238 ↗
  • Ferguson DM, Parker TD, Arshad SA, Garcia EI, Hebballi NB, Tsao K. Standardized Discharge Antibiotics May Reduce Readmissions in Pediatric Perforated Appendicitis. J Surg Res. 2020 Nov;255:388-395. doi: 10.1016/j.jss.2020.05.086. Epub 2020 Jun 29. PubMed 32615311 ↗
  • Javanmard-Emamghissi H, Boyd-Carson H, Hollyman M, Doleman B, Adiamah A, Lund JN, Clifford R, Dickerson L, Richards S, Pearce L, Cornish J, Hare S, Lockwood S, Moug SJ, Tierney GM; COVID: HAREM (Had Appendicitis, Resolved/Recurred Emergency Morbidity/Mortality) Collaborators Group. The management of adult appendicitis during the COVID-19 pandemic: an interim analysis of a UK cohort study. Tech Coloproctol. 2021 Apr;25(4):401-411. doi: 10.1007/s10151-020-02297-4. Epub 2020 Jul 15. Erratum In: Tech Coloproctol. 2021 Jan;25(1):149. doi: 10.1007/s10151-020-02321-7. PubMed 32671661 ↗
  • RIFT Study Group on behalf of the West Midlands Research Collaborative. Appendicitis risk prediction models in children presenting with right iliac fossa pain (RIFT study): a prospective, multicentre validation study. Lancet Child Adolesc Health. 2020 Apr;4(4):271-280. doi: 10.1016/S2352-4642(20)30006-7. Epub 2020 Feb 13. PubMed 32200936 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04707339
Lead sponsor
Princess Alexandra Hospital NHS Trust
Responsible party
Naveed Kirmani (Principal Investigator, Princess Alexandra Hospital NHS Trust) — Principal investigator
First posted
Jan 13, 2021
Start date
Jan 30, 2020
Primary completion
Oct 31, 2020
Completion
Jan 30, 2021 (estimated)
Last update
Jan 14, 2021

Study contacts

Adeel A Dhahri, MRCS
Contact
adeelabbas.dhahri@nhs.net
+447936636920
Naveed Kirmani, FRCS
Contact
naveed.kirmani@nhs.net
01279444455
Naveed Kirmani, FRCS
principal investigator · The Princess Alexandra Hospital NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion